| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.9 |